These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
428 related items for PubMed ID: 9722227
1. Eosinophil markers in seasonal allergic rhinitis. Intranasal fluticasone propionate inhibits local and systemic increases during the pollen season. Nielsen LP, Bjerke T, Christensen MB, Skamling M, Peterson CG, Mygind N, Dahl R. Allergy; 1998 Aug; 53(8):778-85. PubMed ID: 9722227 [Abstract] [Full Text] [Related]
2. Retrospective study on fluticasone propionate aqueous nasal spray efficacy in patients with allergic rhinitis: evaluation of clinical and laboratory parameters. Ventura MT, Piccinni T, Matino MG, Giuliano G, Di Corato R, Di Napoli P, Tursi A. Allergy; 2001 Jan; 56(1):29-34. PubMed ID: 11167349 [Abstract] [Full Text] [Related]
3. Once daily intranasal fluticasone propionate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis. Foresi A, Pelucchi A, Gherson G, Mastropasqua B, Chiapparino A, Testi R. J Allergy Clin Immunol; 1996 Aug; 98(2):274-82. PubMed ID: 8757203 [Abstract] [Full Text] [Related]
12. Steroid-sensitive indices of airway inflammation in children with seasonal allergic rhinitis. Meyer P, Andersson M, Persson CG, Greiff L. Pediatr Allergy Immunol; 2003 Feb; 14(1):60-5. PubMed ID: 12603713 [Abstract] [Full Text] [Related]
13. Alpha2-macroglobulin and eosinophil cationic protein in the allergic airway mucosa in seasonal allergic rhinitis. Meyer P, Persson CG, Andersson M, Wollmer P, Linden M, Svensson C, Greiff L. Eur Respir J; 1999 Mar; 13(3):633-7. PubMed ID: 10232439 [Abstract] [Full Text] [Related]
14. Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: effects of single allergen challenge. Holm A, Dijkstra M, Kleinjan A, Severijnen LA, Boks S, Mulder P, Fokkens W. J Allergy Clin Immunol; 2001 Apr; 107(4):627-33. PubMed ID: 11295650 [Abstract] [Full Text] [Related]
15. Measurement of inflammatory mediators of mast cells and eosinophils in native nasal lavage fluid in nasal polyposis. Di Lorenzo G, Drago A, Esposito Pellitteri M, Candore G, Colombo A, Gervasi F, Pacor ML, Purello D'Ambrosio F, Caruso C. Int Arch Allergy Immunol; 2001 Jun; 125(2):164-75. PubMed ID: 11435734 [Abstract] [Full Text] [Related]
17. Basophil histamine release, IgE, eosinophil counts, ECP, and EPX are related to the severity of symptoms in seasonal allergic rhinitis. Winther L, Moseholm L, Reimert CM, Stahl Skov P, Kaergaard Poulsen L. Allergy; 1999 May; 54(5):436-45. PubMed ID: 10380774 [Abstract] [Full Text] [Related]
18. Fluticasone nasal spray and the combination of loratadine and montelukast in seasonal allergic rhinitis. Saengpanich S, deTineo M, Naclerio RM, Baroody FM. Arch Otolaryngol Head Neck Surg; 2003 May; 129(5):557-62. PubMed ID: 12759270 [Abstract] [Full Text] [Related]
19. Changes in inflammatory markers following treatment of acute exacerbations of obstructive pulmonary disease. Dahlén I, Janson C, Björnsson E, Stålenheim G, Peterson CG, Venge P. Respir Med; 2001 Nov; 95(11):891-7. PubMed ID: 11716203 [Abstract] [Full Text] [Related]
20. Effect of nasal triamcinolone acetonide on seasonal variations of bronchial hyperresponsiveness and bronchial inflammation in nonasthmatic children with seasonal allergic rhinitis. Orhan F, Sekerel BE, Adalioglu G, Pinar M, Tuncer A. Ann Allergy Asthma Immunol; 2004 Apr; 92(4):438-45. PubMed ID: 15104196 [Abstract] [Full Text] [Related] Page: [Next] [New Search]